1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Evotec SE
  6. News
  7. Press Releases
    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société EVOTEC SE
05/19Evotec and Almirall enter into a multi-target alliance in medical dermatology
EQ
05/18Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell re..
AQ
05/17Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based ..
AQ
05/17Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell re..
EQ
05/11Evotec SE reports results for the first quarter 2022 and provides corporate update
EQ
05/10Evotec and Bristol Myers Squibb extend and expand strategic partnership
EQ
05/10Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degr..
EQ
05/04Evotec SE to announce results for the first quarter 2022 on 11 May 2022
EQ
05/03EVOTEC : makes strategic equity investment in antibody drug conjugate specialist Tubulis
PU
04/26EVOTEC : Sustainability Report 2021PDF, 3.9 MB
PU
04/13Evotec SE fiscal year 2021 results, 'Setting the Pace' on the data-driven R&D Autobahn ..
AQ
04/12EVOTEC SE FISCAL YEAR 2021 RESULTS : "Setting the Pace" on the data-driven R&D Autobahn to..
PU
04/12EVOTEC SE FISCAL YEAR 2021 RESULTS : 'Setting the Pace' on the data-driven R&D Autobahn to..
EQ
04/08Kazia - two abstracts at aacr conference present detailed study design and innovative b..
AQ
04/08EVOTEC : achieves programme designation in neuroscience collaboration with Bristol Myers S..
PU
04/08Evotec achieves programme designation in neuroscience collaboration with Bristol Myers ..
EQ
04/05EVOTEC : to announce results for fiscal year 2021 on 12 April 2022
PU
04/05Evotec SE to announce results for fiscal year 2021 on 12 April 2022
EQ
03/31Evotec expands screening capacity at Hamburg headquarters through EFRE/REACT-EU-Grant
AQ
03/22Evotec receives EUR 3 m milestone payment for Bayer starting Phase II clinical developm..
AQ
03/21EVOTEC : receives € 3 m milestone payment for Bayer starting Phase II clinical development..
PU
03/21Evotec receives ? 3 m milestone payment for Bayer starting Phase II clinical developmen..
EQ
03/14EVOTEC : CMO Leadership Awards 2022
PU
03/08EVOTEC : publishes DDup 12 - Evotec`s 3D cell model platform
PU
03/02Evotec expands molecular patient database with unique nephrotic syndrome cohort from th..
AQ
03/02UNIVERSITY OF BRISTOL : Bristol to collaborate with Evotec to help treatment of kidney dis..
AQ
03/02EVOTEC : presents strategic roadmap towards precision medicine and confirms goals of Actio..
PU
03/02Evotec presents strategic roadmap towards precision medicine and confirms goals of Acti..
EQ
03/01Evotec expands molecular patient database with unique nephrotic syndrome cohort from th..
EQ
02/16EVOTEC : participates in Centauri Therapeutics' Series A investment round
PU
02/15EVOTEC : Invests In Data-Driven Biotechnology Company IMIDomics, Inc.
PU
02/07Evotec SE - Bayer discontinues clinical development candidate eliapixant (BAY1817080), ..
AQ
02/04EVOTEC SE : Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evo..
PU
02/04Evotec expands sustainability at Dorothy Crowfoot Hodgkin Campus
AQ
02/04EVOTEC SE : Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evo..
EQ
01/31EVOTEC SE : Preliminary announcement of the publication of quarterly reports and quarterly..
EQ
01/25EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
01/25Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophtha..
EQ
01/18EVOTEC : partner Celmatix achieves milestone for PCOS drug programme
PU
01/18Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
EQ
01/11EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include new targe..
PU
01/11Evotec expands neuroscience collaboration with Bristol Myers Squibb to include new targ..
EQ
01/04EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
01/04Evotec receives EUR 7.5 m grant for development of COVID-19 therapeutic
AQ
01/03EVOTEC : receives € 7.5 m grant for development of COVID-19 therapeutic
PU
01/03Evotec receives ? 7.5 m grant for development of COVID-19 therapeutic
EQ
2021EVOTEC : receives US$ 18 m grant for women's health
PU
2021Evotec receives US$ 18 m grant for women's health
EQ
2021EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership
BU
2021EVOTEC : and EQRx announce integrated drug discovery and development partnership
PU
2021Evotec and EQRx announce integrated drug discovery and development partnership
EQ
2021EVOTEC : announces the exercise of the Greenshoe option
PU
2021Evotec SE reports results for the first nine months 2021 and provides corporate update
PU
2021Evotec SE reports results for the first nine months 2021 and provides corporate update
EQ
2021Evotec reaches programme designations in neuroscience collaboration with Bristol Myers ..
PU
2021Evotec reaches programme designations in neuroscience collaboration with Bristol Myers ..
EQ
2021Evotec SE announces closing of public offering
PU
2021Evotec SE announces closing of public offering
EQ
2021Evotec SE Announces Placement of its Public Offering of American Depositary Shares
PU
2021Evotec SE to announce results for the first nine months 2021 on 11 November 2021
PU
2021Evotec se to announce results for the first nine months 2021 on 11 november 2021
EQ
2021Evotec SE - Translational BRIDGE beLAB2122 in collaboration with Bristol Myers Squibb i..
AQ
2021EVOTEC SE : Translational BRIDGE beLAB2122 in collaboration with Bristol Myers Squibb iden..
PU
2021Evotec announces first funded projects of translational BRIDGE beLAB1407 in collaborati..
PU
2021Evotec SE announces launch of public offering of American Depositary Shares
PU
2021EVOTEC SE : Announces launch of public offering of American Depositary Shares
EQ
2021EVOTEC : provides preliminary nine month financial results
PU
2021EVOTEC : provides preliminary nine month financial results
EQ
2021EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..
AQ
2021EVOTEC : LUMITOS AG - Evotec expands neuroscience collaboration with Bristol Myers Squibb ..
AQ
2021EVOTEC : files registration statement for proposed offering of American Depositary Shares
PU
2021EVOTEC : files registration statement for proposed offering of American Depositary Shares
EQ
2021EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..
PU
2021EVOTEC : expands neuroscience collaboration with Bristol Myers Squibb to include novel cel..
EQ
2021EVOTEC : publishes DDup 11 – AI-driven antibody discovery at Evotec
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on EVOTEC SE